These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 17314232

  • 1. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P, Mahakunkijcharoen Y, Kittigul L, Mahannop P, Pichyangkul S, Hirunpetcharat C.
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [Abstract] [Full Text] [Related]

  • 2. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
    Hirunpetcharat C, Mahakunkijcharoen Y, Jeamwattanalert P, Kittigul L, Mahannop P, Pichyangkul S.
    Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
    [Abstract] [Full Text] [Related]

  • 3. CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
    Hirunpetcharat C, Wipasa J, Sakkhachornphop S, Nitkumhan T, Zheng YZ, Pichyangkul S, Krieg AM, Walsh DS, Heppner DG, Good MF.
    Vaccine; 2003 Jun 20; 21(21-22):2923-32. PubMed ID: 12798636
    [Abstract] [Full Text] [Related]

  • 4. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, Miller LH, Good MF.
    J Immunol; 1997 Oct 01; 159(7):3400-11. PubMed ID: 9317139
    [Abstract] [Full Text] [Related]

  • 5. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY, Leite JA, Lopes SC, Sbrogio-Almeida ME, Braga CJ, Ferreira LC, Soares IS, Costa FT, Rodrigues MM.
    Vaccine; 2010 Apr 01; 28(16):2818-26. PubMed ID: 20170765
    [Abstract] [Full Text] [Related]

  • 6. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
    Bargieri DY, Rosa DS, Braga CJ, Carvalho BO, Costa FT, Espíndola NM, Vaz AJ, Soares IS, Ferreira LC, Rodrigues MM.
    Vaccine; 2008 Nov 11; 26(48):6132-42. PubMed ID: 18804504
    [Abstract] [Full Text] [Related]

  • 7. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
    Kang Y, Calvo PA, Daly TM, Long CA.
    J Immunol; 1998 Oct 15; 161(8):4211-9. PubMed ID: 9780195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.
    Mata E, Carcaboso AM, Hernández RM, Igartua M, Corradin G, Pedraz JL.
    Vaccine; 2007 Jan 15; 25(5):877-85. PubMed ID: 17070628
    [Abstract] [Full Text] [Related]

  • 10. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
    Near KA, Stowers AW, Jankovic D, Kaslow DC.
    Infect Immun; 2002 Feb 15; 70(2):692-701. PubMed ID: 11796601
    [Abstract] [Full Text] [Related]

  • 11. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
    Kumar S, Jones TR, Oakley MS, Zheng H, Kuppusamy SP, Taye A, Krieg AM, Stowers AW, Kaslow DC, Hoffman SL.
    Infect Immun; 2004 Feb 15; 72(2):949-57. PubMed ID: 14742540
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
    Xue X, Ding F, Zhang Q, Pan X, Qu L, Pan W.
    Vaccine; 2010 Apr 19; 28(18):3152-8. PubMed ID: 20197139
    [Abstract] [Full Text] [Related]

  • 15. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
    Matsumoto S, Yukitake H, Kanbara H, Yamada T.
    J Exp Med; 1998 Sep 07; 188(5):845-54. PubMed ID: 9730886
    [Abstract] [Full Text] [Related]

  • 16. Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development.
    Yuen D, Leung WH, Cheung R, Hashimoto C, Ng SF, Ho W, Hui G.
    Vaccine; 2007 Jan 05; 25(3):490-9. PubMed ID: 16949181
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS.
    Vaccine; 2007 Jul 09; 25(28):5166-74. PubMed ID: 17544179
    [Abstract] [Full Text] [Related]

  • 18. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL, Daly TM, Long CA.
    Exp Parasitol; 1999 Jan 09; 91(1):78-85. PubMed ID: 9920045
    [Abstract] [Full Text] [Related]

  • 19. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
    Mehrizi AA, Zakeri S, Rafati S, Salmanian AH, Djadid ND.
    Parasite Immunol; 2011 Nov 09; 33(11):594-608. PubMed ID: 21883290
    [Abstract] [Full Text] [Related]

  • 20. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.
    ten Hagen TL, Sulzer AJ, Kidd MR, Lal AA, Hunter RL.
    J Immunol; 1993 Dec 15; 151(12):7077-85. PubMed ID: 8258712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.